ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,307.01
-0.27%
US Tech 100
18,402.80
0.96%
Dow Jones
39,671.04
-0.51%
Brent Oil
82.31
0.96%
Bitcoin
69,537.03
0.63%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/23/20247:00AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KRMDKORU Medical Systems Inc
05/23/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:KZIAKazia Therapeutics Ltd
05/23/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
05/23/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
05/23/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLNEHamilton Lane Inc
05/23/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:MSSVMeso Numismatics Inc (PK)
05/23/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:LKNCYLuckin Coffee Inc (PK)
05/23/20247:00AMGlobeNewswire Inc.Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium
05/23/20247:00AMGlobeNewswire Inc.ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTSTSXV:ARCARCpoint Inc
05/23/20247:00AMBusiness WireKinaxis sélectionné comme solution d'orchestration de la chaîne d'approvisionnement par Intercos GroupTSX:KXSKinaxis Inc
05/23/20247:00AMGlobeNewswire Inc.Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company NomineesTSXV:MFGMayfair Gold Corp
05/23/20247:00AMGlobeNewswire Inc.Immersive Fishing and Boating Sim ‘Ships at Sea’ from Misc Games Available Now in PC Early Access
05/23/20247:00AMBusiness WireIntercos Group wählt Kinaxis als Lösung zur Orchestrierung der LieferketteTSX:KXSKinaxis Inc
05/23/20247:00AMGlobeNewswire Inc.atai Life Sciences Strengthens Board with Appointment of Two New Independent DirectorsNASDAQ:ATAIATAI Life Sciences NV
05/23/20247:00AMGlobeNewswire Inc.Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’NASDAQ:TLRYTilray Brands Inc
05/23/20247:00AMGlobeNewswire Inc.Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’TSX:TLRYTilray Brands Inc
05/23/20247:00AMBusiness WireSSR Mining Announces Closing of Sale of San Luis Project to Highlander SilverASX:SSRSSR Mining Inc
05/23/20247:00AMBusiness WirePureTech to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
05/23/20247:00AMGlobeNewswire Inc.Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and moreSO6
05/23/20247:00AMGlobeNewswire Inc.Macerich Launches Path-Forward PlanNYSE:MACMacerich Co
05/23/20247:00AMGlobeNewswire Inc.Script Runner launches Canada’s first AI-powered drone delivery service, revolutionizing healthcare access for remote communities
05/23/20247:00AMGlobeNewswire Inc.West Red Lake Gold Strengthens Investor Relations TeamTSXV:WRLGWest Red Lake Gold Mines Ltd
05/23/20247:00AMBusiness WireBicycle Therapeutics Announces $555 Million Private Placement Equity FinancingNASDAQ:BCYCBicycle Therapeutics PLC
05/23/20247:00AMBusiness WireCatalYm to Present Positive New Phase 2a Follow-up Data on GDF-15 Neutralizing Antibody Visugromab in Advanced NSCLC, Urothelial, and Hepatocellular Cancer at the 2024 ASCO Annual Meeting
05/23/20247:00AMGlobeNewswire Inc.Rivalry to Report First Quarter 2024 Results on May 30TSXV:RVLYRivalry Corp
05/23/20247:00AMGlobeNewswire Inc.OTC Markets Group Welcomes Direct Selling Acquisition Corp. to OTCQXNYSE:DSAQDirect Selling Acquisition Corp
05/23/20247:00AMGlobeNewswire Inc.Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference
05/23/20247:00AMBusiness WireTango Therapeutics Announces Discontinuation of TNG348 ProgramNASDAQ:TNGXTango Therapeutics Inc
05/23/20247:00AMGlobeNewswire Inc.DraftKings Completes Acquisition of JackpocketNASDAQ:DKNGDraftKings Inc
05/23/20247:00AMBusiness WireiCell Gene Therapeutics Announces Positive Clinical Data from Investigator Initiated Phase 1 Trial Evaluating BCMA-CD19 Compound CAR in Patients with Systemic Lupus Erythematosus/Lupus Nephritis Published in Annals of the Rheumatic Diseases

Your Recent History

AMEX
GLTA
Galata Acquisition
BIT
P1W148
NLBNPIT1W148 20991231 82...
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved